Demand for Mpox vaccine increases in Berlin and Africa

Demand for the Mpox vaccine has significantly increased in Berlin and Africa. In Berlin, there has been a rise in Mpox cases, particularly among high-risk patients.

However, there is no immediate threat in Germany. In Africa, a new variant of the Mpox virus is spreading rapidly, causing concern among health authorities.

The continent, already struggling with limited resources, is ill-prepared for another pandemic. The Mpox outbreak in Africa is considered an international health emergency.

Efforts are being made to provide vaccines to affected regions, but challenges such as war, corruption, and lack of infrastructure hinder progress. The situation highlights the need for global cooperation and support to combat infectious diseases.